< Back to Newsletter Archive

BIO Newsletter
BIO Newsletter: BIO Launches "Innovation Saves" Ad, BIO Investor Forum Programming Announced
SUBSCRIBE | VIEW ONLINE 09.08.2016
BIO NEWSLETTER
Providing Critical Information About the Industry
VISIT BIO.ORG
BIO Launches "Innovation Saves" Ad to Highlight Value of Biopharmaceutical Innovation
BIO launched a new television ad focused on biopharmaceutical innovation and its unique ability to help both save lives and save money. The new ad, along with its “Innovation Saves” website, is a new chapter in BIO’s Value Campaign, which seeks to highlight the value of biopharmaceutical innovation, the importance of protecting the ecosystem that makes new cures and treatments possible and ensuring that patients have access to these important innovations…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO Investor Forum – Early Bird
BIO INVESTOR FORUM
spacer
BIO Investor Forum 2016 Programming Announcedarrow
SHARE: Share on facebook Share on Twitter Share on LinkedIn
ANIMAL BIOTECH SUMMIT
spacer
Register for the BIO Animal Biotech Summitarrow

SHARE: Share on facebook Share on Twitter Share on LinkedIn
BIO Animal Biotech Summit
Double border
Health Icon INDUSTRIAL & ENVIRONMENTAL
BIO Releases New Report on Renewable Chemical Biorefinery Commercialization
BIO released a new report "Advancing the Biobased Economy: Renewable Chemical Biorefinery Commercialization, Progress, and Market Opportunities, 2016 and Beyond," documenting substantial, ongoing growth in the renewable chemical industry and outlining federal and state policies that support the industry…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Event Icon BIO INVESTOR FORUM
Partnering System, Investment Climate – Big Draws for 2016 BIO Investor Forum
Every fall investors looking for good prospects in the biotech sector gather at the BIO Investor Forum in San Francisco—the birthplace of biotechnology and home to over 1,600 life sciences companies…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Health Icon HEALTH
Peter Pitts Weighs in on Drug Price Debate
Last week in the Sacramento Bee, Peter J. Pitts, a former U.S. Food and Drug Administration associate commissioner and now president of the Center for Medicine in the Public Interest, wrote an op-ed regarding the ongoing drug pricing debate titled "Rising Drug Prices The Fault Of Insurers, Not Drug Companies."
SHARE: Share on facebook Share on Twitter Share on LinkedIn
 
Health Icon HEALTH
Making Biopharmaceutical Innovation a Priority of the Next Administration
Last week, Astellas Americas President Jim Robinson wrote an op-ed in Forbes exploring, "How The Next Administration Embraces Medical Invention."
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
BIO HEALTH
ICYMI: Potential New Drug for Alzheimer’s Shows Promise in Early Trial
Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which highlighted new findings from a paper published in Nature…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Double border
Event Icon ANIMAL BIOTECH SUMMIT
Strong U.S. Government "One Health" Coordination
The concept of "One Health" recognizes that the health of people, animals, and the environment are linked…
SHARE: Share on facebook Share on Twitter Share on LinkedIn
Bio Jobs
Bio Jobs
Bio Jobs
©2016 Biotechnology Innovation Organization. All rights reserved.
About BIO | Privacy Policy | Terms of Use | Subscribe | Unsubscribe | Feedback | Advertising
FOLLOW US: Follow us on Facebook Follow us on Twitter Follow us on LinkedIn Email us